Stelios Papadopoulos, Director at BIOGEN INC. (BIIB), bought 10,000 shares at $304.78 ($3.0M) on 2015-07-27, disclosed to the SEC on 2015-07-27.
Open-market purchase of $3.0M BIIB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $304.78 | 5,000 | $1.5M | 50.0% |
| 2 | $304.98 | 5,000 | $1.5M | 50.0% |
| Total | $304.88 avg | 10,000 | $3.0M | 100% |
| Filing → |
| EXEL | SELL | 2024-05-22 | $240K | — | Filing → |
| EXEL | SELL | 2022-02-24 | $3.3M | — | Filing → |
| EXEL | SELL | 2021-05-13 | $911K | — | Filing → |